SECsense Logo

Mangoceuticals, Inc. 8-K Filing Report: Key Insights and Updates

$MGRX
Form 8-K
Filed on: 2025-02-12
Source
Mangoceuticals, Inc. 8-K Filing Report: Key Insights and Updates

Here are the key insights extracted from the provided financial report section:

  1. Entity Information:
  • Company Name: Mangoceuticals, Inc.
  • CIK (Central Index Key): 0001938046
  • SEC File Number: 001-41615
  • Tax Identification Number: 87-3841292
  • Address: 15110 N. Dallas Parkway, Suite 600, Dallas, TX 75248
  • Contact Number: (214) 242-9619
  1. Filing Information:
  • Filing Type: 8-K
  • Filing Date: February 12, 2025
  1. Stock Information:
  • Common Stock Par Value: $0.0001 per share
  • Stock Symbol: MGRX
  • Exchange: NASDAQ
  1. Reporting Period:
  • As of Date: February 12, 2025
  • Period Start Date: February 12, 2025
  • Period End Date: February 12, 2025
  1. Units of Measure:
  • Monetary Unit: USD (United States Dollar)
  • Shares Unit: Shares

Insights:

  • The report pertains to a significant event (8-K filing) for Mangoceuticals, Inc., which typically indicates a material event or corporate change.
  • The company is actively traded on NASDAQ under the symbol MGRX, suggesting it is a publicly listed entity.
  • The specified par value of common stock is very low, which may indicate a strategy to attract more investors by keeping shares affordable.
  • The details provided are crucial for investors and analysts who track the company's performance and any material developments reported on February 12, 2025.